Article

ACE-2-like Enzymatic Activity in Anti-SARS-CoV-2 Spike Protein Monoclonal Antibodies

2026-02-05

Abstract excerpt

Many people with acute COVID-19 have clinical disease not clearly attributable to viral replication and many COVID-19 convalescents are affected by post-acute sequelae of COVID-19 (PASC, or long COVID, LC). LC has severely affected public health and economies worldwide. Features of LC including blood pressure dysregulation, coagulopathies, high levels of inflammation, and neuropsychiatric complaints. The mechanism...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 429bf9fb-3bb5-51e8-9adb-7bd909b64b02
DOI: 10.64898/2026.02.02.703244

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

ACE-2-like Enzymatic Activity in Anti-SARS-CoV-2 Spike Protein Monoclonal AntibodiesDOI 10.64898/2026.02.02.703244Read

Human anti-ACE2 monoclonal antibodies as pan-sarbecovirus prophylactic agentsSemantic proximity Read

Autoantibodies Targeting Angiotensin Converting Enzyme 2 Are Prevalent and Not Induced by SARS-CoV-2 InfectionSemantic proximity Read

ACE2-based decoy receptors for SARS coronavirus 2.Semantic proximity Read

ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2Semantic proximity Read

A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent in vitroSemantic proximity Read

Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sitesSemantic proximity Read

SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infectionSemantic proximity Read

ACE2 in the Era of SARS-CoV-2: Controversies and Novel PerspectivesSemantic proximity Read

Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodiesSemantic proximity Read

A bioluminescent and homogeneous SARS-CoV-2 spike RBD and hACE2 interaction assay for antiviral screening and monitoring patient neutralizing antibody levels.Semantic proximity Read

Novel ACE2-IgG1 fusions with improved <i>in vitro</i> and <i>in vivo</i> activity against SARS-CoV2Semantic proximity Read

Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection.Semantic proximity Read